- Cantor Fitzgerald has initiated coverage on Clever Leaves Holdings Inc (NASDAQ: CLVR) with an Overweight rating and a price target of $4.50.
- The stock offers better relative "pure-play" exposure to growth in overseas medical cannabis markets and eventually to recreational legalization in those markets, Cantor writes.
- According to the analyst Clever Leaves, a large-scale, low-cost producer of pharmaceutical-grade cannabis, could be among the world's top five cannabinoid exporters by the end of 2023.
- Also See: Clever Leaves To Ship …
Full story available on Benzinga.com
Cannabis Player Clever Leaves Could Have Almost 390% Upside Due To Overseas Exposure, This Analyst Says on Benzinga